Vanguard Group »

Invivo Therapeutics Hldgs shares owned by Vanguard Group

Quarter-by-quarter ownership of Invivo Therapeutics Hldgs (NVIVQ) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Invivo Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Invivo Therapeutics Hldgs held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Invivo Therapeutics Hldgs by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $23k 31k 0.73
2023-09-30 $32k 29k 1.12
2023-06-30 $35k 26k 1.35
2023-03-31 $28k 26k 1.06
2022-12-31 $40k 17k 2.35

More positions owned by Vanguard Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Invivo Therapeutics Hldgs

Goldman Sachs Group
Barclays
Vima
Sugarloaf Wealth Management

View all funds holding Invivo Therapeutics Hldgs